Ubiquinol improves symptoms in children with autism

Anna Gvozdjáková1, Jarmila Kucharská1, Daniela Ostatníková2

  • 1Pharmacobiochemical Laboratory of 3rd Medical Department, Medical Faculty, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.

Insights

Ubiquinol supplementation improved autism symptoms in children, including communication and sleep. This study suggests ubiquinol may be a beneficial therapy for autism spectrum disorder.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatrics

Background:

  • Autism spectrum disorder (ASD) is a neurodevelopmental condition appearing in early childhood, characterized by behavioral issues and sleep/eating disturbances.
  • The exact causes of ASD remain unclear, but oxidative stress and antioxidant roles in its pathophysiology are being investigated.
  • Antioxidants like ubiquinol may play a role in the biochemical pathways associated with autism.

Purpose of the Study:

  • To investigate the efficacy of ubiquinol as a supportive therapy for children diagnosed with autism spectrum disorder.
  • To assess the impact of ubiquinol on behavioral symptoms and specific biomarkers in children with ASD.

Main Methods:

  • A study involving 24 children (aged 3-6 years) diagnosed with autism (DSM IV criteria, CARS assessment).
  • Participants received three months of ubiquinol supplementation (100 mg/day).
  • Plasma levels of CoQ10-TOTAL, tocopherols, beta-carotene, and lipid peroxidation were measured pre- and post-therapy. Parental reports on behavior were collected.

Main Results:

  • Ubiquinol therapy led to improvements in various autism symptoms, including parental communication (12%), verbal communication (21%), play (42%), sleep (34%), and reduced food rejection (17%).
  • Positive outcomes correlated with plasma CoQ10-TOTAL levels exceeding 2.5 μmol/L.
  • Observed improvements suggest a beneficial effect of ubiquinol on core autism-related behaviors.

Conclusions:

  • This study provides the first evidence of ubiquinol's beneficial effects in children with autism.
  • Plasma CoQ10-TOTAL concentration and lipid peroxidation levels may serve as useful biomarkers for monitoring ubiquinol therapy effectiveness in ASD.
  • Ubiquinol shows promise as an adjunctive treatment for managing symptoms in children with autism spectrum disorder.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
2.0K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
4.6K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
823
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967